Last reviewed · How we verify

NCT07319624: BePeSEIT

Bedside PEEP Selection in by Electrical Impedence Tomography During Mechanical Ventilation in Children

Completed NA Last updated 6 January 2026
What this trial tests

NA trial testing Electrical Impedence Tomography in Pneumonia in 14 participants. Completed in 30 April 2025.

Timeline
1 December 2024
Primary endpoint
30 April 2025
30 April 2025

Quick facts

Lead sponsorPapa Giovanni XXIII Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment14
Start date1 December 2024
Primary completion30 April 2025
Estimated completion30 April 2025
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Papa Giovanni XXIII Hospital

Who can join

Adults 0 to 3, any sex, with Pneumonia or Tetralogy of Fallot Correction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective study evaluates the feasibility and safety of using Electrical Impedance Tomography (EIT) to guide PEEP selection in mechanically ventilated infants and toddlers under 3 years of age. This population is challenging for its variety and anatomophysiologic peculiarity. A decremental PEEP trial using 1 cmH₂O steps following a recruitment maneuver at 35 cmH₂O was compared between EIT and other best PEEP assessment protocols.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pneumonia

Currently open trials in the same condition.

Other Papa Giovanni XXIII Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07319624.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing